Fonar Corp (FONR)
16.45
+1.56
(+10.48%)
USD |
NASDAQ |
Nov 21, 16:00
16.10
-0.35
(-2.13%)
After-Hours: 20:00
Fonar Revenue (Quarterly): 24.96M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 24.96M |
| June 30, 2024 | 25.94M |
| March 31, 2024 | 25.72M |
| December 31, 2023 | 25.39M |
| September 30, 2023 | 25.84M |
| June 30, 2023 | 25.78M |
| March 31, 2023 | 25.42M |
| December 31, 2022 | 24.26M |
| September 30, 2022 | 23.19M |
| June 30, 2022 | 24.81M |
| March 31, 2022 | 24.57M |
| December 31, 2021 | 24.48M |
| September 30, 2021 | 23.73M |
| June 30, 2021 | 24.70M |
| March 31, 2021 | 23.09M |
| December 31, 2020 | 21.16M |
| September 30, 2020 | 20.98M |
| June 30, 2020 | 20.81M |
| March 31, 2020 | 21.69M |
| December 31, 2019 | 21.45M |
| September 30, 2019 | 21.75M |
| June 30, 2019 | 22.48M |
| March 31, 2019 | 22.78M |
| December 31, 2018 | 21.22M |
| September 30, 2018 | 20.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 21.04M |
| March 31, 2018 | 20.98M |
| December 31, 2017 | 20.17M |
| September 30, 2017 | 19.33M |
| June 30, 2017 | 20.89M |
| March 31, 2017 | 20.01M |
| December 31, 2016 | 18.40M |
| September 30, 2016 | 18.73M |
| June 30, 2016 | 18.77M |
| March 31, 2016 | 18.62M |
| December 31, 2015 | 18.37M |
| September 30, 2015 | 17.61M |
| June 30, 2015 | 16.88M |
| March 31, 2015 | 17.10M |
| December 31, 2014 | 17.09M |
| September 30, 2014 | 17.98M |
| June 30, 2014 | 17.02M |
| March 31, 2014 | 17.04M |
| December 31, 2013 | 17.61M |
| September 30, 2013 | 16.83M |
| June 30, 2013 | 18.38M |
| March 31, 2013 | 11.64M |
| December 31, 2012 | 9.613M |
| September 30, 2012 | 9.511M |
| June 30, 2012 | 10.99M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
20.81M
Minimum
Jun 2020
25.94M
Maximum
Jun 2024
23.90M
Average
24.52M
Median
Revenue (Quarterly) Benchmarks
| XWELL Inc | 8.422M |
| ProPhase Labs Inc | 3.146M |
| Applied DNA Sciences Inc | 0.7975M |
| Veracyte Inc | 115.86M |
| OncoCyte Corp | 0.115M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.135M |
| Total Expenses (Quarterly) | 20.35M |
| EPS Diluted (Quarterly) | 0.46 |
| Enterprise Value | 41.17M |
| Gross Profit Margin (Quarterly) | 40.24% |
| Profit Margin (Quarterly) | 12.56% |
| Earnings Yield | 8.51% |
| Operating Earnings Yield | 13.75% |
| Normalized Earnings Yield | 6.788 |